basic descriptive methods.
Results
Three patients were male and 7 were female. Average age at time of diagnosis was 75.5. 9 patients had a pathologic diagnosis of basal cell carcinoma and one had a diagnosis of primary neuroendocrine tumour. All 10 patients had tumour on the nose, and one also had a tumour on the upper lip. 8/10 patients had T1N0 tumour stage, while in the remaining two it was T2N0. 40 Gy in 10 fractions was the most commonly prescribed dose in 6 patients. 250 KeV was the chosen photon energy in the majority (7/10) of patients.
Lead shields created using 3D printing were remarkably accurate, fitting the contours of the patient's face perfectly in each case.
Conclusion
This is the first cohort of patients with facial skin cancer who had lead shields created for ortho-voltage radiation treatment using optical scanner and 3D printer technology. This method saves valuable clinical time and resources and adds patient convenience. The cost of manufacture is also very affordable. A significant number of patients suffer from claustrophobia and inability to lie flat, and this is addressed using this technology. We recommend that the use of optical scanner and 3D printer technology to generate lead shielding in RT of non-melanoma facial skin cancer become the new standard of care.
